Researchers from OSF Healthcare and its partners have developed an artificial intelligence algorithm that can predict the upcoming week’s work for each cancer patient navigator’s existing patients – and a second machine learning model…
Continue Reading
By Mark Melchionna
June 27, 2023 – A new predictor-informed distribution model that leverages artificial intelligence, developed by researchers at OSF Healthcare and the OSF Innovation group, eased the workflow of cancer patient navigators while limiting…
Continue Reading
Researchers from King’s College Hospital NHS Foundation Trust are trialling an artificial intelligence (AI) tool designed to support the analysis of endoscopy findings by helping doctors identify abnormalities to speed up diagnoses.The trial will…
Continue Reading
NHS trusts will be able to bid for funding to accelerate the deployment of the most promising artificial intelligence (AI) tools after Secretary of State for Health and Social Care Steve Barclay announced a…
Continue Reading
Around 10,000 people living across the North East will be trialling the PocDoc Lipid Test, which can indicate whether someone has high cholesterol with an at-home finger prick blood test, a lateral flow device…
Continue Reading
The Sussex Pathology Network has selected Clinisys for the deployment of a laboratory information system (LIMS) that will help its labs to collaborate and maintain a high-quality pathology service for clinicians, patients and residents.A…
Continue Reading
British health tech company TidalSense has published results from clinical studies which demonstrated more than 91 percent accuracy in diagnosing severe chronic obstructive pulmonary disease (COPD) from a single breath recording using its artificially…
Continue Reading
What You Should Know:
Mindpeak, a leading provider of artificial intelligence (AI) for pathology, and Proscia®, a leading provider of digital and computational pathology solutions, have announced a partnership to broaden access to improved diagnosis for cancer…
Continue Reading
The antibody index (AI) is a measure of local antibody synthesis in the central nervous system (CNS) and represents an important and growing tool in neurological diagnostics. Determination of the AI supports diagnosis of…
Continue Reading
Huma Therapeutics has received US Food and Drug Administration (FDA) Class II clearance for its disease-agnostic Software-as-a-Medical-Device (SaMD) platform, enabling companies to launch their own algorithm innovations more quickly to the platform and allowing…
Continue Reading
